Fisher & Paykel Healthcare Corporation Ltd (FPH) - Total Assets
Based on the latest financial reports, Fisher & Paykel Healthcare Corporation Ltd (FPH) holds total assets worth AU$2.61 Billion AUD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Fisher & Paykel Healthcare Corporation Ltd - Total Assets Trend (2000–2025)
This chart illustrates how Fisher & Paykel Healthcare Corporation Ltd's total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Fisher & Paykel Healthcare Corporation Ltd - Asset Composition Analysis
Current Asset Composition (March 2025)
Fisher & Paykel Healthcare Corporation Ltd's total assets of AU$2.61 Billion consist of 36.7% current assets and 63.3% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 10.4% |
| Accounts Receivable | AU$304.60 Million | 11.9% |
| Inventory | AU$342.90 Million | 13.4% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$82.10 Million | 3.2% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Fisher & Paykel Healthcare Corporation Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fisher & Paykel Healthcare Corporation Ltd's current assets represent 36.7% of total assets in 2025, a decrease from 48.2% in 2000.
- Cash Position: Cash and equivalents constituted 10.4% of total assets in 2025, up from 0.6% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 13.4% of total assets.
Fisher & Paykel Healthcare Corporation Ltd Competitors by Total Assets
Key competitors of Fisher & Paykel Healthcare Corporation Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MENICON CO.LTD
F:5FR
|
Germany | €187.06 Billion |
|
Unicon Optical Co., Ltd.
TWO:4150
|
Taiwan | NT$1.12 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
Fisher & Paykel Healthcare Corporation Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.09 | 2.06 | 1.91 |
| Quick Ratio | 1.37 | 1.17 | 1.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$508.27 Million | AU$395.00 Million | AU$283.83 Million |
Fisher & Paykel Healthcare Corporation Ltd - Advanced Valuation Insights
This section examines the relationship between Fisher & Paykel Healthcare Corporation Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.77 |
| Latest Market Cap to Assets Ratio | 5.09 |
| Asset Growth Rate (YoY) | 11.8% |
| Total Assets | AU$2.55 Billion |
| Market Capitalization | $12.98 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Fisher & Paykel Healthcare Corporation Ltd's assets at a significant premium (5.09x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Fisher & Paykel Healthcare Corporation Ltd's assets grew by 11.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Fisher & Paykel Healthcare Corporation Ltd (2000–2025)
The table below shows the annual total assets of Fisher & Paykel Healthcare Corporation Ltd from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | AU$2.55 Billion | +11.79% |
| 2024-03-31 | AU$2.28 Billion | +10.58% |
| 2023-03-31 | AU$2.06 Billion | +5.72% |
| 2022-03-31 | AU$1.95 Billion | +2.29% |
| 2021-03-31 | AU$1.91 Billion | +37.27% |
| 2020-03-31 | AU$1.39 Billion | +19.98% |
| 2019-03-31 | AU$1.16 Billion | +20.17% |
| 2018-03-31 | AU$964.08 Million | +19.80% |
| 2017-03-31 | AU$804.74 Million | +16.28% |
| 2016-03-31 | AU$692.09 Million | +3.33% |
| 2015-03-31 | AU$669.82 Million | +6.27% |
| 2014-03-31 | AU$630.33 Million | +1.90% |
| 2013-03-31 | AU$618.60 Million | +8.14% |
| 2012-03-31 | AU$572.05 Million | +10.52% |
| 2011-03-31 | AU$517.61 Million | +8.96% |
| 2010-03-31 | AU$475.06 Million | +14.82% |
| 2009-03-31 | AU$413.74 Million | +24.74% |
| 2008-03-31 | AU$331.67 Million | +20.75% |
| 2007-03-31 | AU$274.67 Million | +2.69% |
| 2006-03-31 | AU$267.47 Million | +16.13% |
| 2005-03-31 | AU$230.31 Million | +2.74% |
| 2004-03-31 | AU$224.17 Million | -2.00% |
| 2003-03-31 | AU$228.75 Million | +6.23% |
| 2002-03-31 | AU$215.33 Million | -9.02% |
| 2001-03-31 | AU$236.69 Million | -48.46% |
| 2000-03-31 | AU$459.22 Million | -- |
About Fisher & Paykel Healthcare Corporation Ltd
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The com… Read more